Cough syrup is a medication used to treat cough and related symptoms such as sore throat, congestion, and chest discomfort. It contains a combination of active ingredients that work to suppress coughing and alleviate other symptoms.
Cough syrup is available in liquid form and is usually taken orally. It is important to follow the instructions on the label carefully and to use the medication only as directed. Overuse or misuse of cough syrup can lead to side effects such as drowsiness, dizziness, nausea, and difficulty breathing.
Request Report Sample- https://www.alliedmarketresearch.com/request-sample/10677
The global cough syrup market was valued at $5,232.73 million in 2019, and is projected to reach $6,108.25 million by 2027, registering a CAGR of 2.8% from 2020 to 2027.
Cough Syrup Market Key Players-
Here are some key players in the cough syrup market up until that point:
Pfizer Inc.
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc.
Reckitt Benckiser Group plc.
Novartis AG
AstraZeneca plc.
Sanofi S.A.
Procter & Gamble Co.
Merck & Co., Inc.
Boehringer Ingelheim GmbH
These companies are some of the largest and most established players in the global cough syrup market. They are engaged in research and development activities to improve the efficacy and safety of cough syrup products, and they have a wide distribution network to ensure availability of their products in various regions of the world.
Procure Complete Report (240 Pages PDF with Insights, Charts, Tables, and Figures) @ – https://www.alliedmarketresearch.com/checkout-final/5eb12bc0232e5cd176da563f05490570
By age group, the adult segment is expected to register the highest CAGR during the forecast period, owing to the fact that cough syrups are mainly recommended to the adult age group by the government and pediatric age group cannot be provided with OTC cough syrups without any prescription.
By region, Asia-Pacific accounted for the largest share of revenue in 2019, and is anticipated to maintain its dominance from 2020 to 2027 due to easier availability of cough syrups at retail pharmacies, rise in geriatric population, and less stricter laws regarding the abuse of cough & cold medicines in the region. However, LAMEA is expected to register the highest CAGR during the forecast period as governments are investing in the development of healthcare infrastructure and increasing cases of respiratory disorder.
Speak to our analyst – https://www.alliedmarketresearch.com/connect-to-analyst/10677
Related Reports –
Sterility Indicators Market – https://www.alliedmarketresearch.com/sterility-indicator-market-A29031
Sharps Containers Market – https://www.alliedmarketresearch.com/sharps-containers-market-A17525